Pathways to wellness

How Fat Cells Store and Release Energy: New 2026 Research on Insulin, Leptin & Exercise

September 9, 2026

Fat cells are not passive storage bags. New 2026 studies reveal how insulin directs lipid storage, exercise signals help mobilize fuel, leptin communicates with the brain, and obesity may alter brain glucose sensing—without turning new molecular findings into unproven treatments.

Mindful Diabetes cover illustration showing an adipocyte receiving insulin signals, releasing stored fatty acids during exercise, and sending leptin signals toward the brain.
Mindful Diabetes cover illustration showing an adipocyte receiving insulin signals, releasing stored fatty acids during exercise, and sending leptin signals toward the brain.

Fat cells are often described as little more than storage containers: calories come in, fat goes in, and weight goes up.

The biology is far more interesting.

An adipocyte—the cell that makes up much of our body fat—is a highly responsive metabolic cell. It listens to insulin after we eat. It stores triglycerides inside specialized organelles called lipid droplets. During fasting or exercise, it can mobilize those stores. It releases hormones such as leptin that communicate with the brain. And the brain, in turn, monitors nutrient and hormonal signals and helps coordinate whole-body energy balance.

During just nine days—from August 31 through September 8, 2026—four new studies added striking new pieces to this conversation. One identified a previously poorly understood insulin-responsive enzyme in human adipocytes. Another showed how receptor trafficking can influence exercise-related fat mobilization in male mice. A third clarified how β3-adrenergic signaling affects leptin. And a fourth profiled 75,787 individual nuclei to ask how a high-fat diet changes the brain's transcriptional response to glucose.

Together, the studies make one point especially clear:

Healthy fat tissue is not simply good at storing energy or good at releasing it. Healthy metabolism depends on being able to switch appropriately between storage, mobilization, hormonal communication, and nutrient sensing.

The short version

If you only remember a few things from this article, make them these:

  • Storing fat inside an adipocyte is a normal physiological function—not automatically a metabolic failure.
  • A new 2026 human-adipocyte study identified PLCXD1 as part of the machinery that helps insulin direct glucose-derived carbon toward lipid storage.
  • Lipid droplets are dynamic organelles, not inert blobs of oil.
  • During exercise and other states of increased energy demand, adrenergic signaling helps adipose tissue mobilize stored triglycerides.
  • A new mouse study suggests CNIH4 helps β-adrenergic receptors reach or function at the correct cellular location.
  • Fat cells also release leptin, which helps communicate information about energy stores to the brain.
  • Another 2026 mouse study found that β3-adrenergic signaling influences leptin levels—but is not required for leptin to fall during a 48-hour fast.
  • In a new single-nucleus study, a high-fat diet profoundly altered the transcriptional response to elevated glucose in several brain-cell populations.
  • Feeling or looking bloated over a few hours is not the same thing as suddenly accumulating large amounts of body fat.

That last point matters because body weight, abdominal appearance, adipose expansion, gastrointestinal distension, and metabolic health are often discussed as though they were interchangeable.

They are not.

Fat is not passive storage

Adipose tissue is sometimes portrayed as a problem we would be healthier without.

That is not how normal physiology works.

Adipocytes perform several essential jobs: they take up nutrients, synthesize and store triglycerides, release fatty acids when energy demand rises, respond to insulin and nervous-system signals, remodel their size and surrounding tissue, and secrete hormones and signaling molecules that influence the rest of the body.

A detailed Cell Metabolism review on insulin action in adipocytes describes adipose tissue as a highly insulin-responsive organ that contributes to whole-body nutrient homeostasis—not a passive warehouse. A broader Cell review of adipose-tissue plasticity similarly emphasizes how dynamically fat tissue changes with feeding, fasting, temperature, exercise, obesity, and disease.

This distinction also helps separate dietary fat from stored body fat. The fats we eat are nutrients with different structures and health effects; adipose triglycerides are the body's long-term energy-storage form. If you want the nutrition side of that story, our Mindful Diabetes guide to dietary fats explains saturated, unsaturated, and trans fats without treating all fat as one category.

When insulin says "store": a new PLCXD1 pathway in human fat cells

The strongest new discovery for this article arrived on September 3, 2026, in Nature Communications.

Scott Frendo-Cumbo and colleagues integrated multiple transcriptomic datasets and then functionally tested insulin-responsive genes in human adipocytes. They identified 43 genes that were consistently regulated by insulin and focused on one particularly intriguing hit: phospholipase C X domain-containing protein 1, or PLCXD1. Read the full PLCXD1 study.

PLCXD1 was not simply another marker that happened to rise after insulin exposure.

The investigators found that:

  • insulin induced PLCXD1 through the transcription factors SREBP1 and SREBP2;
  • that induction was attenuated in insulin-resistant states;
  • PLCXD1 localized primarily to early endosomes;
  • the protein could convert phosphatidylinositol (PI) into diacylglycerol (DAG);
  • PLCXD1 catalytic activity was required for normal insulin-stimulated lipogenesis.

When PLCXD1 was depleted, insulin-stimulated lipid synthesis fell. DAG and triglyceride content decreased. Lipid-droplet area decreased.

Yet glucose uptake remained intact.

That is an unusually useful mechanistic result because it separates glucose entering the adipocyte from what the cell subsequently does with some of that carbon.

Infographic showing insulin activating SREBP1 and SREBP2, increasing PLCXD1 in a human adipocyte, and supporting PI-to-DAG metabolism and triglyceride storage.
Original Mindful Diabetes visualization based on Frendo-Cumbo et al., 2026. PLCXD1 helps connect insulin-regulated transcription to lipid storage in human adipocytes.

The important takeaway is not that PLCXD1 is a newly discovered "fat-gain gene."

The study does not show that blocking PLCXD1 would be a safe or useful weight-loss strategy in people. It does not show that PLCXD1 causes obesity. It does not show that insulin itself is harmful.

What it gives us is a new molecular piece of the normal process by which insulin helps an adipocyte route nutrients toward lipid storage.

Lipid droplets are not the enemy

Inside an adipocyte, triglyceride is stored in structures called lipid droplets.

The name sounds simple, but lipid droplets are bona fide cellular organelles. A 2026 review in RSC Chemical Biology describes them as dynamic hubs whose growth, remodeling, and breakdown are coordinated with nutrient status, hormonal signals, membrane synthesis, lipid oxidation, and cellular stress. Read the 2026 lipid-droplet review.

That means "storing fat" is not automatically the problem.

In fact, the ability of adipose tissue to safely buffer incoming energy can be protective.

After a meal, energy has to go somewhere. Healthy adipocytes can package triglycerides inside lipid droplets and later mobilize those stores when needed. Problems can emerge when adipose tissue becomes unable to expand, remodel, or respond appropriately and excess lipid begins to accumulate in tissues that are not specialized for long-term energy storage.

This concept is sometimes called ectopic fat.

Gerald Shulman's classic review in The New England Journal of Medicine explains how lipid accumulation in tissues such as the liver and skeletal muscle can participate in insulin resistance and cardiometabolic disease. Read the ectopic-fat review.

Infographic comparing healthy adipose lipid storage with dysfunctional adipose remodeling and ectopic lipid accumulation in non-adipose tissues.
Storing triglyceride in adipose tissue is normal. Metabolic problems can emerge when storage, remodeling, signaling, and mobilization become dysfunctional.

This is also why the phrase "fat is bad" is biologically unhelpful.

A better question is:

Where is lipid being stored, how well can that tissue handle it, and can the system switch appropriately between storage and release?

Insulin resistance is not simply an ON/OFF switch

Public explanations of insulin resistance often imply that a cell either "listens to insulin" or it does not.

Human biology is more selective.

In a 2021 study of human white adipose tissue, researchers used hyperinsulinemic-euglycemic clamps and RNA sequencing to show that obesity was associated with selective insulin resistance: some insulin-responsive transcriptional programs remained active, while others were attenuated. Read the human adipose selective-insulin-resistance study.

The new PLCXD1 study fits into that more nuanced picture. PLCXD1 remained an insulin-responsive gene, but its insulin-induced expression was attenuated in insulin-resistant states.

So insulin resistance should not be imagined as a master switch snapping from "on" to "off."

Different branches of insulin signaling can become disrupted to different degrees.

That matters because simplistic statements such as "insulin makes you store fat, therefore insulin is the problem" ignore why insulin-directed nutrient storage exists in the first place.

Healthy metabolism requires a fed state and a mobilization state.

When the body needs energy, the signal changes

Hours after eating—or during exercise—metabolism shifts.

Insulin concentrations tend to fall, while sympathetic nervous-system activity and catecholamine signaling can rise. β-adrenergic receptors on adipocytes activate pathways involving cAMP and PKA, which engage proteins associated with lipid-droplet breakdown and lipolysis.

The result is regulated conversion of stored triglycerides into fatty acids and glycerol that can be released and used elsewhere.

A 2025 Physiological Reviews article on human glucose and fatty-acid metabolism describes how dramatically substrate storage and mobilization change from the fed state to overnight fasting and physical activity, and also emphasizes that these responses can differ between men and women. Read the human metabolic-physiology review.

Then, on September 8, 2026, a new Nature Communications study added another layer: receptor trafficking.

Researchers studying Cornichon homolog 4 (CNIH4) found that the protein helps regulate β-adrenergic receptor localization and activity in metabolic tissues. In adipose tissue, loss of CNIH4 weakened β3-adrenergic signaling, thermogenesis, and exercise-induced lipolysis. Read the CNIH4 study.

Infographic showing beta-3 adrenergic signaling, CNIH4 receptor trafficking, cAMP and PKA, and the breakdown of stored triglyceride into fatty acids and glycerol during energy demand.
Adrenergic signaling helps mobilize stored adipose fuel. New 2026 mouse research implicates CNIH4 in beta-adrenergic receptor trafficking and metabolic adaptation.

There is a crucial limitation here:

The detailed adipose mechanism was demonstrated primarily in male mice.

The paper did report increased CNIH4 expression in human and mouse skeletal muscle following resistance training, but that does not make CNIH4 a proven human obesity target.

It would be inappropriate to translate the study into "activate CNIH4 to burn more fat."

The much safer conclusion is that even receptor placement and trafficking are regulated parts of the cellular response to energy demand.

For the practical side of physical activity, our older walking-with-diabetes guide focuses on an accessible behavior rather than trying to manipulate one molecular pathway.

Fat cells talk back: leptin is part of the conversation

Adipose tissue does not just receive instructions.

It also sends information.

One of its best-known hormonal signals is leptin, which is produced largely by adipocytes and communicates with brain circuits involved in energy balance, food intake, neuroendocrine function, and metabolism. Modern reviews describe leptin as an adiposity signal rather than simply a "fullness hormone." Read an open-access review of leptin and energy balance.

A new study published September 1, 2026 asked a more specific question:

Does β3-adrenergic signaling directly inside adipocytes regulate leptin, and is that pathway responsible for the sharp fall in leptin during fasting?

The investigators created mice in which β3-adrenergic-receptor signaling could be globally blocked and then selectively restored in adipocytes. Global loss of β3-AR increased circulating leptin. Restoring β3-AR expression specifically in adipocytes normalized leptin and restored the ability of β3 stimulation to suppress it. Read the Heaselgrave et al. study.

So β3-adrenergic signaling clearly mattered.

But then came the surprise.

After 48 hours of fasting, circulating leptin and adipose leptin expression still fell substantially even when β3-adrenergic signaling was absent.

Infographic showing leptin traveling from an adipocyte to the hypothalamus and comparing leptin regulation with and without beta-3 adrenergic receptor signaling during a 48-hour mouse fast.
Beta-3 adrenergic signaling regulates leptin, but the 2026 mouse study found that it was not required for fasting-induced leptin suppression.

That means:

β3-adrenergic signaling helps regulate leptin—but it is not the whole fasting signal.

The study does not yet tell us what all of those alternative mechanisms are.

It also used male mice and a 48-hour fast, which should not be casually equated with a human 12-hour overnight fast or a 16:8 eating schedule.

For a broader look at the very different question of whether fasting is clinically useful in diabetes, see our separate 2026 evidence review: Intermittent Fasting and Diabetes in 2026: Helpful Tool, Overhyped Trend, or Both?

The brain is listening too

The fourth new paper moves us from adipose tissue into the central nervous system.

On August 31, 2026, Jenny Brown and colleagues reported a single-nucleus RNA-sequencing study asking how cells in the hypothalamus and brainstem respond to elevated glucose—and whether a high-fat diet changes that response. Read the Nature Communications study.

The scale of the experiment was substantial:

75,787 nuclei were profiled.

The investigators sampled three metabolically important regions:

  • the arcuate nucleus;
  • the ventromedial hypothalamus;
  • the dorsal vagal complex.

Male mice were fed either a control diet or a high-fat diet for eight weeks and then received intravenous glucose or saline.

In control-diet animals, hyperglycemia triggered transcriptional responses across several populations. The paper highlighted conserved responses in astrocytes and oligodendrocytes, as well as a response in Ghrh neurons.

After the high-fat diet, many of those glucose-responsive transcriptional programs were largely absent or reversed.

Split-screen infographic comparing glucose-responsive transcription in brain cells of control-diet and eight-week high-fat-diet male mice, with a badge noting 75,787 nuclei profiled.
Brown et al. profiled 75,787 nuclei and found that many glucose-responsive transcriptional programs were absent or reversed after high-fat feeding in male mice.

This result deserves careful wording.

The investigators measured transcriptional responses, not a direct electrical readout of every neuron firing or failing to fire.

The study was performed in male mice, not people.

And it does not tell us whether every change was a cause of obesity, a consequence of obesity, an adaptation to the diet, or some combination of those processes.

Still, it gives us an unusually detailed cellular map suggesting that chronic diet-induced obesity can alter the way multiple brain-cell populations respond to glucose.

That is a far richer picture than simply saying "the brain senses blood sugar."

So why can someone look or feel bigger after a single meal?

This is where it is important to separate adipose biology from bloating and abdominal distension.

If your abdomen looks noticeably larger this evening than it did this morning, that does not mean your adipocytes suddenly accumulated enough triglyceride to explain the entire visible change.

Abdominal bloating and distension can involve intestinal contents, gas handling, bowel motility, fluid, visceral sensitivity, and even the way the diaphragm and abdominal wall respond to gut sensations. A 2024 review describes functional bloating and distension as complex disorders of gut-brain interaction rather than simply "too much gas." Read the bloating and distension review.

So it helps to distinguish three different concepts:

Bloating — the subjective sensation of fullness, pressure, or gas.

Abdominal distension — a measurable increase in abdominal girth.

Adipose expansion — changes in fat-cell size and/or fat-cell number as energy is stored over time.

These processes can coexist, but they are not the same thing.

Rapid changes across a day are much more likely to reflect gastrointestinal contents, fluid shifts, or distension physiology than a dramatic change in total body-fat mass.

Why can losing excess body fat still be difficult?

The answer is also more complicated than "fat cells are too good at storing fat."

In obesity, adipose tissue can develop changes that affect:

  • insulin responsiveness;
  • catecholamine responsiveness;
  • inflammatory signaling;
  • extracellular-matrix remodeling and fibrosis;
  • adipokine signaling;
  • thermogenic function;
  • lipid storage and mobilization.

A recent 2026 review on thermogenic adipose-tissue dysfunction in aging and obesity describes how impaired β3-adrenergic/PKA signaling, immune pathways, and tissue remodeling can constrain normal adipose function.

That means metabolic dysfunction is not simply a state in which adipocytes become perfect storage machines.

In some circumstances, they become worse at switching appropriately between storage, release, endocrine signaling, and tissue remodeling.

The new PLCXD1, CNIH4, leptin, and brain-glucose-sensing studies each illuminate a different point along that larger network.

Store. Release. Signal. Sense.

We can now put the story together.

STORE

After a meal, glucose and insulin rise. Insulin promotes nutrient uptake and lipid synthesis. The new PLCXD1 study identifies one additional mechanism helping human adipocytes route metabolism toward triglyceride storage.

RELEASE

When energy demand rises, adrenergic signaling can activate adipose lipolysis. The CNIH4 study suggests receptor trafficking itself helps determine how effectively that signal is transmitted.

SIGNAL

Adipocytes release leptin and other adipokines, communicating information about long-term energy stores and metabolic status to the brain and other tissues.

SENSE

The hypothalamus and brainstem integrate nutrients and hormones. Brown and colleagues show that chronic high-fat feeding can profoundly alter glucose-responsive transcriptional programs in multiple brain-cell populations.

This is why metabolism is better understood as a network than as one switch.

What does this mean for everyday health?

These studies are mechanistic. None identifies a new do-it-yourself weight-loss trick.

There is no evidence here that a person should:

  • try to suppress PLCXD1;
  • seek a CNIH4 supplement;
  • manipulate leptin without medical care;
  • exercise specifically to "activate β3 receptors";
  • avoid insulin because insulin supports fat storage.

The practical message is much less sensational:

Our metabolic systems evolved to move repeatedly between feeding, storage, movement, mobilization, sleep, and recovery.

Long-term habits that support those systems still matter.

For nutrition, our Truth About Fats and Fats Without Fear guide separates dietary-fat quality from the simplistic idea that eating fat automatically means gaining body fat.

For an eating pattern centered on whole foods, vegetables, legumes, fish, olive oil, and other minimally processed foods, see our Mediterranean Diet guide.

For physical activity, walking is one of the most accessible places to start.

And for turning knowledge into repeatable routines around meals, activity, sleep, hydration, and daily goals, you can explore Memovela.

The goal is not to micromanage every molecule.

It is to give the biology the conditions in which normal metabolic flexibility has a chance to work.

The 2026 takeaway

The most interesting lesson from this cluster of new research is not that scientists found one new "fat switch."

They found more evidence that there is no single switch.

Insulin-responsive transcription helps determine how nutrients are stored. Lipid droplets actively organize that storage. Adrenergic receptors have to be trafficked and activated appropriately for mobilization. Fat cells send endocrine information back to the brain. The brain itself responds to nutrients through multiple neuronal and glial populations, and those responses can change in obesity.

Healthy adipose tissue therefore needs to do more than store less fat.

It needs to:

store when storage is appropriate,

release when energy is needed,

signal accurately to the rest of the body,

and exist within a nervous and endocrine system that can still sense and respond to changing metabolic conditions.

That is a much more useful way to think about body fat than treating it as a passive enemy.


Continue exploring

Educational information only. This article summarizes emerging basic and translational research and is not medical advice. Findings from animal or cell studies should not be interpreted as treatment recommendations for people.

Scientific sources and further reading

  1. Frendo-Cumbo S, Zareifi D, Bigay J, et al. Functional annotation of insulin-responsive genes in human adipocytes reveals PLCXD1 as a lipid storage regulator. Nature Communications. 2026;17:9458. doi:10.1038/s41467-026-77280-y.
  2. Liu X, Wang Z, Chen S, et al. CNIH4 regulates systemic metabolism and exercise adaptations in male mice primarily through the modulation of β-adrenergic receptor trafficking. Nature Communications. 2026. doi:10.1038/s41467-026-77408-0.
  3. Heaselgrave SR, Wyler SC, Thomas S, et al. Adipocyte β3-Adrenergic Receptor Signaling Attenuates Leptin Production but Is Dispensable for Fasting Induced Leptin Suppression. American Journal of Physiology-Endocrinology and Metabolism. 2026. doi:10.1152/ajpendo.00083.2026.
  4. Brown JM, Bentsen MA, Jørgensen AM, et al. Single-cell profiling identifies obesity-disrupted brain glucose sensing. Nature Communications. 2026. doi:10.1038/s41467-026-77116-9.
  5. Santoro A, McGraw TE, Kahn BB. Insulin action in adipocytes, adipose remodeling, and systemic effects. Cell Metabolism. 2021;33(4):748-757. doi:10.1016/j.cmet.2021.03.019.
  6. Weiskirchen R, Weiskirchen S, Lonardo A. Lipid droplet dynamics in metabolic regulation. RSC Chemical Biology. 2026;7:517-535. doi:10.1039/D6CB00081A.
  7. Sakers A, De Siqueira MK, Seale P, Villanueva CJ. Adipose-tissue plasticity in health and disease. Cell. 2022;185(3):419-446. doi:10.1016/j.cell.2021.12.016.
  8. Shulman GI. Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease. New England Journal of Medicine. 2014;371:1131-1141. doi:10.1056/NEJMra1011035.
  9. Mileti E, Kwok KHM, Andersson DP, et al. Human White Adipose Tissue Displays Selective Insulin Resistance in the Obese State. Diabetes. 2021;70(7):1486-1497. doi:10.2337/db21-0001.
  10. Costa DN, Santosa S, Jensen MD. Sex differences in the metabolism of glucose and fatty acids by adipose tissue and skeletal muscle in humans. Physiological Reviews. 2025;105(3):897-934. doi:10.1152/physrev.00008.2024.
  11. Ortiz GU, Abud GF, Fogagnolo C, et al. Mechanistic Drivers of Thermogenic Adipose Tissue Dysfunction in Aging and Obesity. American Journal of Physiology-Endocrinology and Metabolism. 2026. doi:10.1152/ajpendo.00105.2026.
  12. Asgari R, Caceres-Valdiviezo M, Wu S, et al. Regulation of energy balance by leptin as an adiposity signal and modulator of the reward system. Molecular Metabolism. 2025;91:102078. doi:10.1016/j.molmet.2024.102078.
  13. Crucillà S, Caldart F, Michelon M, et al. Functional Abdominal Bloating and Gut Microbiota: An Update. Microorganisms. 2024;12(8):1669. doi:10.3390/microorganisms12081669.

Keep reading